Virulence factor expression by Gram-positive cocci exposed to subinhibitory concentrations of linezolid
Open Access
- 20 September 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 50 (5) , 665-672
Abstract
Linezolid is a new oxazolidinone with potent antibacterial activity against Gram-positive cocci; it uniquely inhibits bacterial translation through inhibition of 70S initiation complex formation. The effects of sub-growth-inhibitory concentrations of linezolid on the expression of various structural and soluble virulence factors of Staphylococcus aureus and Streptococcus pyogenes were examined. For S. aureus, strains Wood 46 and Cowan 1 (NCTC 8532) were used to measure protein A, coagulase, α-haemolysin (hla) and δ-haemolysin (hld). For S. pyogenes, strain NCTC 9994 was used to measure M protein, streptolysin O (SLO) and DNase. Coagulase was assayed by clotting of citrated rabbit plasma, and hla, hld and SLO by lysis of rabbit, human and horse erythrocytes, respectively. Protein A and M protein were measured indirectly using bacterial susceptibility to phagocytic ingestion of radiolabelled bacteria by human neutrophils. When S. aureus was grown in 1/2, 1/4 and 1/8 MIC, linezolid, coagulase, hla and hld production were impaired. Susceptibility to phagocytosis was changed by growth in the presence of 1/2 MIC linezolid compared with that in its absence (50.8 ± 4.1% versus 38.9 ± 2.9%; P ≤ 0.05). When S. pyogenes was grown in 1/2, 1/4 and 1/8 MIC linezolid, SLO and DNase production were impaired compared with that of bacteria grown in the absence of the drug; its susceptibility to phagocytosis was also increased (52.8% bacteria ingested versus 37.5%; P ≤ 0.05). A reduction in virulence factor expression at sub-MIC linezolid concentrations may be of benefit in the treatment of Gram-positive infections.Keywords
This publication has 19 references indexed in Scilit:
- The Flesh‐Eating Bacterium: What's Next?The Journal of Infectious Diseases, 1999
- Staphylococcus aureus: A Well–Armed PathogenClinical Infectious Diseases, 1998
- Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycinThe Lancet, 1997
- Role of certain virulence factors in a murine model of Staphylococcus aureus arthritisJournal of Medical Microbiology, 1997
- Effects of Environmental Factors on Streptococcal Erythrogenic Toxin A (SPE A) Production by Streptococcus pyogenes1997
- Streptolysin O Modulates Cytokine Synthesis in Human Peripheral Blood Mononuclear Cells1997
- Streptococcal Infections of Skin and Soft TissuesNew England Journal of Medicine, 1996
- Antibiotics and the expression of staphylococcal virulenceJournal of Antimicrobial Chemotherapy, 1995
- The Antibody Responses in Man to Infection with Different Serotypes of Group-a StreptococciJournal of Medical Microbiology, 1974
- Isolation and Composition of Staphylococcal Alpha ToxinJournal of General Microbiology, 1963